Sara Doimo1, Fabrizio Ricci2, Nay Aung3, Jackie Cooper4, Redha Boubertakh3, Mihir M Sanghvi3, Gianfranco Sinagra5, Steffen E Petersen3. 1. Cardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste, Trieste, Italy. Electronic address: sarozza@gmail.com. 2. Department of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University, Chieti, Italy; Department of Clinical Sciences, Malmo, Faculty of Medicine, Lund University, Clinical Research Center, 214 28 Malmo, Sweden; Casa di Cura Villa Serena, Città Sant'Angelo, 65013 Pescara, Italy. 3. William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, UK; Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London, UK. 4. William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, UK. 5. Cardiovascular Department, Azienda Sanitaria Universitaria Integrata, University of Trieste, Trieste, Italy.
Abstract
PURPOSE: To test the diagnostic performance of cardiovascular magnetic resonance (CMR) tissue-tracking (TT) to detect the presence of late gadolinium enhancement (LGE) in patients with a diagnosis of myocardial infarction (MI) or myocarditis (MYO), preserved left ventricular ejection fraction (LVEF) and no visual regional wall motion abnormalities (RWMA). METHODS: We selected consecutive CMR studies of 50 MI, 50 MYO and 96 controls. Receiving operating characteristic (ROC) curve and net reclassification index (NRI) analyses were used to assess the predictive ability and the incremental diagnostic yield of 2D and 3D TT-derived strain parameters for the detection of LGE and to measure the best cut-off values of strain parameters. RESULTS: Overall, cases showed significantly reduced 2D global longitudinal strain (2D-GLS) values compared with controls (-20.1 ± 3.1% vs -21.6 ± 2.7%; p = 0.0008). 2D-GLS was also significantly reduced in MYO patients compared with healthy controls (-19.7 ± 2.9% vs -21.9 ± 2.4%; p = 0.0001). 3D global radial strain (3D-GRS) was significantly reduced in MI patients compared with controls with risk factors (34.3 ± 11.8% vs 40.3 ± 12.5%, p = 0.024) Overall, 2D-GLS yielded good diagnostic accuracy for the detection of LGE in the MYO subgroup (AUROC 0.79; NRI (95% CI) = 0.6 (0.3, 1.02) p = 0.0004), with incremental predictive value beyond risk factors and LV function parameters (p for AUROC difference = 0.048). In the MI subgroup, 2D-GRS (AUROC 0.81; NRI (95% CI) = 0.56 (0.17, 0.95) p = 0.004), 3D-GRS (AUROC 0.82; NRI (95% CI) = 0.57 (0.17, 0.97) p = 0.006) and 3D global circumferential strain (3D-GCS) (AUROC 0.81; NRI (95% CI) = 0.62 (0.22, 1.01) p = 0.002) emerged as potential markers of disease. The best cut-off for 2D-GLS was -21.1%, for 2D- and 3D-GRS were 39.1% and 37.7%, respectively, and for 3D-GCS was -16.4%. CONCLUSIONS: At CMR-tissue tracking analysis, 2D-GLS was a significant predictor of LGE in patients with myocarditis but preserved LVEF and no visual RWMA. Both 2D- and 3D-GRS and 2D-GCS yielded good diagnostic accuracy for LGE detection in patients with previous MI but preserved LVEF and no visual RWMA.
PURPOSE: To test the diagnostic performance of cardiovascular magnetic resonance (CMR) tissue-tracking (TT) to detect the presence of late gadolinium enhancement (LGE) in patients with a diagnosis of myocardial infarction (MI) or myocarditis (MYO), preserved left ventricular ejection fraction (LVEF) and no visual regional wall motion abnormalities (RWMA). METHODS: We selected consecutive CMR studies of 50 MI, 50 MYO and 96 controls. Receiving operating characteristic (ROC) curve and net reclassification index (NRI) analyses were used to assess the predictive ability and the incremental diagnostic yield of 2D and 3D TT-derived strain parameters for the detection of LGE and to measure the best cut-off values of strain parameters. RESULTS: Overall, cases showed significantly reduced 2D global longitudinal strain (2D-GLS) values compared with controls (-20.1 ± 3.1% vs -21.6 ± 2.7%; p = 0.0008). 2D-GLS was also significantly reduced in MYO patients compared with healthy controls (-19.7 ± 2.9% vs -21.9 ± 2.4%; p = 0.0001). 3D global radial strain (3D-GRS) was significantly reduced in MI patients compared with controls with risk factors (34.3 ± 11.8% vs 40.3 ± 12.5%, p = 0.024) Overall, 2D-GLS yielded good diagnostic accuracy for the detection of LGE in the MYO subgroup (AUROC 0.79; NRI (95% CI) = 0.6 (0.3, 1.02) p = 0.0004), with incremental predictive value beyond risk factors and LV function parameters (p for AUROC difference = 0.048). In the MI subgroup, 2D-GRS (AUROC 0.81; NRI (95% CI) = 0.56 (0.17, 0.95) p = 0.004), 3D-GRS (AUROC 0.82; NRI (95% CI) = 0.57 (0.17, 0.97) p = 0.006) and 3D global circumferential strain (3D-GCS) (AUROC 0.81; NRI (95% CI) = 0.62 (0.22, 1.01) p = 0.002) emerged as potential markers of disease. The best cut-off for 2D-GLS was -21.1%, for 2D- and 3D-GRS were 39.1% and 37.7%, respectively, and for 3D-GCS was -16.4%. CONCLUSIONS: At CMR-tissue tracking analysis, 2D-GLS was a significant predictor of LGE in patients with myocarditis but preserved LVEF and no visual RWMA. Both 2D- and 3D-GRS and 2D-GCS yielded good diagnostic accuracy for LGE detection in patients with previous MI but preserved LVEF and no visual RWMA.
Authors: Amardeep Ghosh Dastidar; Jonathan C L Rodrigues; Anna Baritussio; Chiara Bucciarelli-Ducci Journal: Heart Date: 2015-12-30 Impact factor: 5.994
Authors: Sebastian J Buss; Birgit Krautz; Nina Hofmann; Yannick Sander; Lukas Rust; Sorin Giusca; Christian Galuschky; Sebastian Seitz; Evangelos Giannitsis; Sven Pleger; Philip Raake; Patrick Most; Hugo A Katus; Grigorios Korosoglou Journal: Int J Cardiol Date: 2015-01-07 Impact factor: 4.164
Authors: Hirohiko Motoki; Allen G Borowski; Kevin Shrestha; Richard W Troughton; W H Wilson Tang; James D Thomas; Allan L Klein Journal: J Am Coll Cardiol Date: 2012-10-17 Impact factor: 24.094
Authors: Manesh R Patel; Richard D White; Suhny Abbara; David A Bluemke; Robert J Herfkens; Michael Picard; Leslee J Shaw; Marc Silver; Arthur E Stillman; James Udelson Journal: J Am Coll Cardiol Date: 2013-04-23 Impact factor: 24.094
Authors: Kan N Hor; William M Gottliebson; Christopher Carson; Erin Wash; James Cnota; Robert Fleck; Janaka Wansapura; Piotr Klimeczek; Hussein R Al-Khalidi; Eugene S Chung; D Woodrow Benson; Wojciech Mazur Journal: JACC Cardiovasc Imaging Date: 2010-02
Authors: Toshinari Onishi; Samir K Saha; Antonia Delgado-Montero; Daniel R Ludwig; Tetsuari Onishi; Erik B Schelbert; David Schwartzman; John Gorcsan Journal: J Am Soc Echocardiogr Date: 2015-01-07 Impact factor: 5.251
Authors: Ulf K Radunski; Gunnar K Lund; Dennis Säring; Sebastian Bohnen; Christian Stehning; Bernhard Schnackenburg; Maxim Avanesov; Enver Tahir; Gerhard Adam; Stefan Blankenberg; Kai Muellerleile Journal: Clin Res Cardiol Date: 2016-07-07 Impact factor: 5.460